Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus

Details for Australian Patent Application No. 2002234453 (hide)

Owner Oncolytics Biotech Inc.

Inventors Thompson, Bradley G.; Coffey, Matthew C.

Agent Cullen & Co

Pub. Number AU-B-2002234453

PCT Pub. Number WO2002/066040

Priority 60/270,363 20.02.01 US

Filing date 19 February 2002

Wipo publication date 4 September 2002

Acceptance publication date 17 May 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/704 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 Drugs for genital or sexual disorders

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-B-2002234453

21 April 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Oncolytics Biotech, Inc. to Oncolytics Biotech Inc.

17 May 2007 Application Accepted

  Published as AU-B-2002234453

20 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002234454-WASTEWATER TREATMENT SYSTEM

2002234452-SYSTEM, COMPUTER PROGRAM, AND METHOD FOR PROCESSING ELECTRONIC HEALTH RECORDS